Shapiro, S. B., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2024). Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-024-01434-4
L. Azoulay
First name
L.
Last name
Azoulay
Simms-Williams, N. ., Treves, N. ., Yin, H. ., Lu, S. ., Yu, O. ., Pradhan, R. ., … Azoulay, L. . (2024). Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. Bmj, 385, e078242. http://doi.org/10.1136/bmj-2023-078242
Douros, A. ., Ante, Z. ., Fallone, C. A., Azoulay, L. ., Renoux, C. ., Suissa, S. ., & Brassard, P. . (2024). Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer’s disease: A population-based nested case-control study. Alzheimers Dement, 20, 1716–1724. http://doi.org/10.1002/alz.13561
Shapiro, S. B., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2024). Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.16039
Pradhan, R. ., H. Y. Yu, O. ., Platt, R. W., & Azoulay, L. . (2023). Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study. BMJ Open Diabetes Res Care, 11. http://doi.org/10.1136/bmjdrc-2023-003550
Douros, A. ., Ante, Z. ., Fallone, C. A., Azoulay, L. ., Renoux, C. ., Suissa, S. ., & Brassard, P. . (2023). Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer’s disease: A population-based nested case-control study. Alzheimers Dement. http://doi.org/10.1002/alz.13561
Rouette, J. ., McDonald, E. G., Schuster, T. ., Matok, I. ., Brophy, J. M., & Azoulay, L. . (2023). Thiazide Diuretics and Risk of Colorectal Cancer: A Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwad171
Abrahami, D. ., D’Andrea, E. ., Yin, H. ., Kim, S. C., Paik, J. M., Wexler, D. ., … Patorno, E. . (2023). Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom. Diabetes Obes Metab. http://doi.org/10.1111/dom.15196
Ayele, H. T., Reynier, P. ., Azoulay, L. ., Platt, R. W., Cabaussel, J. ., Benayoun, S. ., & Filion, K. B. (2023). The Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Am J Med. http://doi.org/10.1016/j.amjmed.2023.06.021
Doherty, N. ., Cardwell, C. R., Murchie, P. ., Hill, C. ., Azoulay, L. ., & Hicks, B. . (2023). 5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Cancer Epidemiol Biomarkers Prev. http://doi.org/10.1158/1055-9965.epi-22-1109